Displaying 1 - 2 of 2
| Active Ingredient | ITRACONAZOLE |
| Therapeutic Class | AZOLES |
| Indications | Treatment of vulvovaginal candidiasis, dermatophytoses unresponsive to topical treatment, systemic infections. |
| Caution |
Abdominal pain; diarrhoea, dysnoea; headache; hepatitis; hypokalaemia; nausea; rash; taste disturbances; vomiting. Itraconazole should be avoided in patients with ventricular dysfunction or a history More ... |
| Dose Range | Adult: Vulvovaginal candidiasis: 200mg twice daily for 1 day , Recurrent Vulvovaginal candidiasis: 50-100mg daily for 6 months. Systemic candidiasis: 100-200mg once daily . |
| Drug Interactions | |
| Pregnancy | Manufacturer advises use only in lifethreatening situations (toxicity at high do More ... |
| Breast Feeding | Small amounts present in milkâmay accumulate; manufacturer advises avoid. |
| Active Ingredient | ITRACONAZOLE | SECNIDAZOLE |
| Therapeutic Class | AZOLES |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |